CA 27-29

Tumor marker for breast cancer

CA 27.29 is a tumor marker for breast cancer.[1]

It is a form of glycoprotein MUC1.[2]

## References

[edit]

1. ^ "Definition of CA 27-29. From MedicineNet. Last Editorial Review: 6/14/2012". Archived from the original on 2014-02-25. Retrieved 2008-10-29.
2. ^ Kurian, Sobha; Khan, Mudussara; Grant, Maurice (Dec 2008). "CA 27-29 in patients with breast cancer with pulmonary fibrosis". Clin Breast Cancer. 8 (6): 538–40\. doi:10.3816/CBC.2008.n.067. PMID 19073511.

This oncology article is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

* v
* t
* e

Tumor markers

Blood|

| Lymphoma|

* Neprilysin

|

Lymphosarcoma|

* CD3
* CD79a

Endocrine|

| Thyroid cancer|

* Thyroglobulin
* Medullary thyroid cancer (Calcitonin
* Carcinoembryonic antigen)

|

Pheochromocytoma|

* Normetanephrine
* Enolase 2

Neuroendocrine tumors|

* Synaptophysin
* Chromogranin A

Neuroblastoma|

* Homovanillic acid

Nervous system|

| Brain tumor|

* PCNA

|

Astrocytoma|

* Glial fibrillary acidic protein

NC/Melanoma|

* S100 protein
* Melanoma inhibitory activity

Cardiovascular/
respiratory|

| Lung cancer|

* Carcinoembryonic antigen
* Enolase 2
* Autocrine motility factor
* hPG80

|

Hemangiosarcoma (endothelium)|

* Factor VIII

Digestive|

| Colorectal cancer|

* CA19-9
* Carcinoembryonic antigen
* hPG80

|

Pancreatic cancer|

* CA19-9
* Carcinoembryonic antigen
* CA 242
* Tumor-associated glycoprotein 72
* hPG80

Hepatocellular carcinoma|

* Alpha-fetoprotein/AFP-L3

Reproductive/
urinary/
breast|

| Ovarian tumor|

* Surface epithelial-stromal tumor
* CA-125
* EC
* CD30
* hCG
* EST
* Alpha-fetoprotein
* Choriocarcinoma
* hCG
* Dysgerminoma
* LDH
* Sertoli–Leydig cell tumour
* Testosterone
* GCT
* Inhibin
* hPG80

|

Testicular cancer|

* βhCG
* Alpha-fetoprotein/AFP-L3
* CD30
* hPG80

Prostate cancer|

* Prostate-specific antigen
* Prostatic acid phosphatase
* Glutamate carboxypeptidase II
* erbB-3 receptor
* Early prostate cancer antigen-2
* SPINK1
* GOLM1
* PCA3
* TMPRSS2
* hPG80

Germ cell tumor|

* NANOG

Bladder cancer|

* erbB-3 receptor
* NMP22

Breast cancer|

* CA 15-3
* erbB-2 receptor
* erbB-3 receptor
* Cathepsin D
* CA 27-29
* hPG80

General histology|

| Sarcoma|

* Vimentin

|

Carcinoma (epithelium)|

* Cytokeratin

Musculoskeletal|

| Rhabdomyosarcoma|

* Desmin

|

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template